Hormonal Contraceptives Market, By Product, By Hormone, By Age Group, By End User, By Geography

Description

Hormonal Contraceptives Market is estimated to be valued at USD 17.9 Bn in 2026 and is expected to reach USD 23.7 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.2% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 17.9 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.20%	2033 Value Projection:	USD 23.7 Bn

Hormonal contraception is one of the contraceptive methods that act on the endocrine system. Several types of female hormones are used to prevent ovulation and avoid fertilization. Hormonal contraception can also cause changes in the uterus, making pregnancy less likely. Based on product, the market is segmented into oral contraceptive pills, injectable birth control, emergency contraceptive pills, vaginal ring and transdermal patches. These are safe and reliable forms of hormonal contraceptives to prevent pregnancy. Hormonal contraception has several potential benefits such as they can reduce the risk of uterine cancer, ovarian cancer, and colon cancer. They generally reduce menstrual (menstrual) blood flow. They can reduce painful periods and are very effective in preventing pregnancy.

Market Dynamics

Increased awareness about the benefits and use of contraceptives is a major factor driving the global hormonal contraceptives market. The ever-increasing global population, particularly in developing economies such as India, Brazil, China and others, is a growing source of concern around the world, necessitating government initiatives such as public awareness campaigns to eliminate or reduce the risk of unwanted pregnancies, abortion risks, and the threat of sexual disorders. For instance, according to data from the World Health Organization (WHO), 16 million girls between the ages of 15 and 19 give birth each year, which represents approximately 11% of all births in the world. To prevent these unintended births, the World Health Organization have launched global awareness programs such as This is your life, this is your future. The London Family Planning Summit urged governments, international agencies and other private sectors to commit to improving the accessibility of voluntary family planning.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global hormonal contraceptives market based on the following parameters - company highlights, types portfolio, key highlights, financial performance, and market strategies
Key companies covered as a part of this study include The Female Health Company, Teva Pharmaceutical Industries Limited, Bayer AG, Pfizer, Inc., Mylan N.V., Johnson & Johnson, Ansell Ltd., Mayer Laboratories, Merck & Co., Inc., Church & Dwight, Co., Inc., Afaxys, Inc., Allergan plc., Agile Therapeutics, Apothecus Pharmaceutical Corporation., Novartis AG, Sun Pharmaceutical Industries Ltd., and Cipla Limited.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global hormonal contraceptives market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hormonal contraceptives market

Market Segmentation

By Product (Revenue, USD Bn, 2021-2033)
Oral Contraceptive Pills
Injectable Birth Control
Emergency Contraceptive Pills
Vaginal Ring
Transdermal Patches
By Hormone (Revenue, USD Bn, 2021-2033)
Progestin Only Contraceptive
Combined Hormonal Contraceptive
By Age Group (Revenue, USD Bn, 2021-2033)
15-24 Years
25-34 Years
35-44 Years
Above 44 Years
By End User (Revenue, USD Bn, 2021-2033)
Hospitals
Homecare
Gynecology Centers
Clinics
Ambulatory Surgical Centers
By Region (Revenue, USD Bn, 2021-2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Key Players
The Female Health Company
Teva Pharmaceutical Industries Limited
Bayer AG
Pfizer, Inc.
Mylan N.V.
Johnson & Johnson
Ansell Ltd.
Mayer Laboratories
Merck & Co., Inc.
Church & Dwight, Co., Inc.
Afaxys, Inc.
Allergan plc.
Agile Therapeutics
Apothecus Pharmaceutical Corporation.
Novartis AG
Sun Pharmaceutical Industries Ltd.
Cipla Limited.

Product Code: CMI4615

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Hormone
- Market Snapshot, By Age Group
- Market Snapshot, By End User
- Market Snapshot, By Region
- Market Opportunity Map

3. Global Hormonal Contraceptives Market Insights

Drivers
Restraints
Opportunity
Impact Analysis
Pipeline Analysis
Market Trends
Product Launches
Key Developments
Regulatory Scenario
Reimbursement Scenario
Merger and Acquisition
Epidemiology
PEST Analysis
SWOT Analysis

4. Global Hormonal Contraceptives Market, By Product, 2021-2033 (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Oral Contraceptive Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
Injectable Birth Control
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
Emergency Contraceptive Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
Vaginal Ring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
Transdermal Patches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)

5. Global Hormonal Contraceptives Market, By Hormone, 2021-2033 (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Progestin Only Contraceptive
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
Combined Hormonal Contraceptive
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)

6. Global Hormonal Contraceptives Market, By Age Group, 2021-2033 (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
15-24 Years
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
25-34 Years
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
35-44 Years
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
Above 44 Years
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)

7. Global Hormonal Contraceptives Market, By End User, 2021-2033 (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
Homecare
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
Gynecology Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033 (USD Bn)

8. Global Hormonal Contraceptives Market, By Region, 2021-2033 (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Region at Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Hormone, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Hormone, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Hormone, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Hormone, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Hormone, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Hormone, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast By Value, and Y-o-Y Growth, By Country/Region, 2021-2033, (USD Bn)
  - South Africa
  - Central Africa
  - North Africa

9. Competitive Snapshot

Company Profiles
- The Female Health Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Teva Pharmaceutical Industries Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Bayer AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Pfizer, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Mylan N.V.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Johnson & Johnson
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Ansell Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Mayer Laboratories
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Merck & Co., Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Church & Dwight, Co., Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Afaxys, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Allergan plc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Agile Therapeutics
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Apothecus Pharmaceutical Corporation.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Novartis AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Sun Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Cipla Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

10. Section

Research Methodology
About us